Capital World Investors Novartis Ag Put Options Transaction History
Capital World Investors
- $597 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NVS
# of Institutions
1,434Shares Held
138MCall Options Held
1.48MPut Options Held
1.55M-
Dodge & Cox San Francisco, CA12.2MShares$1.35 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.35 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$820 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$819 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$657 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $238B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...